✦ LIBER ✦

Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

✍ Scribed by Carolyn F. Deacon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The development of non-peptide glucagon-

✍ Ho-Sang Moon; Mi-Kyung Kim; Moon-Ho Son 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 620 KB

Dipeptidyl peptidase-4 inhibitors in the

✍ C. F. Deacon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

Optimization of 1,4-Diazepan-2-one-Conta

✍ Gui-Bai Liang; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

The metabolite generated by dipeptidyl-p

✍ M. Zander; S. Madsbad; C. F. Deacon; J. J. Holst 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 128 KB

Therapy of type 2 diabetes mellitus base

✍ Jens Juul Holst 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Glucagon-Like Peptide-1: The Basis of a

✍ Lotte Bjerre Knudsen 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 10 KB 👁 2 views